In 2023, the export of veterinary drugs of the VIC Group of Companies increased by 80%

Despite the difficult geopolitical situation, we continue cooperation with the European Union. The approval for supply to the Netherlands was extended and we began registering the drugs in Bulgaria. In January we received 2 certificates, 4 more will be ready in the near future,” said Tigran Avakyan, HEAD of the EXPORT sales department of the VIK Group.

The sterile injection solutions produced by our company are in greatest demand on the international market. We are also preparing to introduce a new line of injection suspensions.

In 2024 , we set ourselves ambitious goals:

increase exports by 33%; strengthen our presence in the Southeast Asian, South American and MENA markets; increase the number of drug registrations in other countries to 150.